SURGISCREENRecalls & reported problems across all models

We found 2 models of SURGISCREEN by Ortho-Clinical Diagnostics, Inc. in the FDA's device registry (GUDID). Together they are named in 30 adverse event reports in the FDA's MAUDE database, received between Dec 9, 2022 and Apr 17, 2026 — classified as 2 deaths, 28 malfunctions.

The most frequently reported specific device problem is “False Negative Result” (29 reports).

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event. Widely used products collect more reports, so totals can't be used to compare products or estimate failure rates. Only reports that name a model's exact device identifier are counted. What reports can and can't tell you · How this data works

Most reported SURGISCREEN problems

SURGISCREEN models

2 models, most reported first. Each model has its own page with its reports, recalls and device details.

• SURGISCREEN 6902316
  2 deaths27 reports
• SURGISCREEN 719100
  3 reports

Recent SURGISCREEN adverse event reports

The 15 most recent reports across all models, in the reporter's own words as published by the FDA.

• MalfunctionApr 17, 2026False Negative Result

  (B)(6) ON 24MAR2026, A CUSTOMER CONTACTED THE ORTHO GLOBAL TECHNICAL SOLUTION CENTER (GTSC) AFTER OBSERVING WHAT WAS DESCRIBED AS DISCORDANT NEGATIVE REACTIONS FOR ANTIBODY SCREEN AND ANTIBODY IDENTIFICATION FOR ONE PATIENT SAMPLE USING 0.8% SURGISCREEN LOT VSS727 AND 0.8% RESOLVE PANEL A LOT VRA506 WITH ORTHO MTS ANTI-IGG GEL CARD LOT 110825001-12 ON THEIR ORTHO VISION SWIFT ID-MTS (50004113). COMPLAINANT: (B)(6) MEDICAL TECHNOLOGIST; (B)(6); (B)(6) MEDICAL CENTER (B)(6) USA. DATE OF EVENT: (B)(6) 2026, REPORTED ON 24MAR2026 REAGENTS: 0.8% SURGISCREEN LOT VSS727, EXPIRATION: 14APR2026, MANUFACTURE: 10FEB2026 0.8% RESOLVE PANEL A LOT VRA506, EXPIRATION: 14APR2026, MANUFACTURE: 10FEB2026 MTS ANTI-IGG GEL CARD LOT 110825001-12, EXPIRATION: 04SEP2026, MANUFACTURE: 04DEC2025 OTHER REAGENTS: 3% SURGISCREEN LOT 3SS792, EXPIRATION: 31MAR2026 INSTRUMENT: ORTHO VISION SWIFT ID-MTS, SN (B)(6); SW VERSION: 5.17.0 PATIENT INFORMATION: SAMPLE ID: (B)(6); ENCRYPTED SAMPLE ID: (B)(6). PATIENT HAD PREVIOUSLY IDENTIFIED ANTI-M(MNS1) ANTIBODY. PATIENT WAS NOT TRANSFUSED WITH ANY UNITS POSITIVE FOR M(MNS1) ANTIGEN. NO FURTHER INFORMATION PROVIDED. THE CUSTOMER REPORTED THAT ON (B)(6) 2026, A SAMPLE F

  Patient problems: No Clinical Signs, Symptoms or Conditions

  MAUDE report 24916810 ↗
• MalfunctionApr 17, 2026False Negative Result

  REPORT 1 OF 2 (B)(4) / RA614154 ON 27MAR2026, A CUSTOMER CONTACTED THE ORTHO GLOBAL TECHNICAL SOLUTION CENTER (GTSC) AFTER OBSERVING WHAT WAS DESCRIBED AS DISCORDANT NEGATIVE REACTIONS FOR ANTIBODY SCREEN FOR ONE PATIENT USING 0.8% SURGISCREEN LOT: VSS728 WITH ORTHO MTS ANTI-IGG GEL CARD LOT: 110825001-06 ON THEIR ORTHO VISION SWIFT ID-MTS (B)(6). COMPLAINANT: (B)(6), MEDICAL TECHNOLOGIST; (B)(6) CUSTOMER (B)(6) (B)(6) HOSPITAL (B)(6) USA DATE OF EVENT: 26MAR2026 AND 29MAR2026, REPORTED ON 27MAR2026 REAGENTS: 0.8% SURGISCREEN LOT: VSS728, EXPIRATION: 14APR2026, MANUFACTURE: 10FEB2026 MTS ANTI-IGG GEL CARD LOT: 110825001-06, EXPIRATION: 24AUG2026, MANUFACTURE: 24NOV2025 OTHER REAGENTS: 0.8% RESOLVE PANEL A LOT: VRA506, EXPIRATION: 14APR2026 INSTRUMENT: ORTHO VISION SWIFT ID-MTS S/N: (B)(6); SW VERSION 5.16.0 PATIENT INFORMATION: PATIENT HAS A HISTORY OF AN ANTI-JKA (JK1) ANTIBODY. SAMPLE 1 ID: (B)(6); ENCRYPTED ID- 80-FE-55-7D-8F-8B-E6-88-26-F1-EA-8C-6A-39-F9-8F-A9-A4-3F-67-F9-49-6D-BC-C8-0F-5D-4D-A6-B3-02-DD SAMPLE 2 ID: (B)(6); ENCRYPTED ID- 62-EF-E0-B7-F6-C9-A3-C2-62-0A-BF-09-50-10-3B-0B-E2-1C-58-00-43-44-27-76-11-BC-9D-C1-C2-DC-7B-8D THE CUSTOMER REPORTED THAT ON (B)(6) 2026, SA

  Patient problems: No Clinical Signs, Symptoms or Conditions

  MAUDE report 24910283 ↗
• MalfunctionApr 17, 2026False Negative Result

  REPORT 2 OF 2. (B)(4). ON 27MAR2026, A CUSTOMER CONTACTED THE ORTHO GLOBAL TECHNICAL SOLUTION CENTER (GTSC) AFTER OBSERVING WHAT WAS DESCRIBED AS DISCORDANT NEGATIVE REACTIONS FOR ANTIBODY SCREEN FOR ONE PATIENT USING 0.8% SURGISCREEN LOT VSS728 WITH ORTHO MTS ANTI-IGG GEL CARD LOT 110825001-06 ON THEIR ORTHO VISION SWIFT ID-MTS (B)(6). (B)(6). DATE OF EVENT: (B)(6) 2026 AND (B)(6) 2026, REPORTED ON 27MAR2026. REAGENTS: 0.8% SURGISCREEN LOT VSS728, EXPIRATION: 14APR2026, MANUFACTURE: 10FEB2026 MTS ANTI-IGG GEL CARD LOT 110825001-06, EXPIRATION: 24AUG2026, MANUFACTURE: 24NOV2025. OTHER REAGENTS: 0.8% RESOLVE PANEL A LOT VRA506, EXPIRATION: 14APR2026 INSTRUMENT: ORTHO VISION SWIFT ID-MTS S/N (B)(6); SW VERSION 5.16.0 PATIENT INFORMATION: PATIENT HAS A HISTORY OF AN ANTI-JKA(JK1) ANTIBODY. SAMPLE 1 ID- (B)(6); ENCRYPTED ID- (B)(6). SAMPLE 2 ID- (B)(6); ENCRYPTED ID- (B)(6). THE CUSTOMER REPORTED THAT ON (B)(6) 2026, SAMPLE 1 FROM THE PATIENT WAS TESTED FOR ANTIBODY SCREEN USING 0.8% SURGISCREEN LOT VSS728 WITH MTS ANTI-IGG GEL CARD LOT 110825001-06 ON THE ORTHO VISION SWIFT ID-MTS ANALYZER (B)(6) AND A NEGATIVE REACTION WAS OBTAINED WITH ALL THREE SCREENING CELLS. THE CUSTOMER REPORTE

  Patient problems: No Clinical Signs, Symptoms or Conditions

  MAUDE report 24910280 ↗
• MalfunctionJan 30, 2026False Negative Result

  REPORT 2 OF 2 (B)(4) A CUSTOMER CONTACTED ORTHO (B)(6) ON (B)(6) 2026 TO REPORT WHAT WAS DESCRIBED AS DISCORDANT NEGATIVE REACTIONS FOR ANTIBODY SCREEN IN INDIRECT ANTIGLOBULIN TEST (IAT) USING MANUAL GEL METHOD, FOR TWO PATIENT SAMPLES UTILIZING REAGENT RED BLOOD CELLS SURGISCREEN LOT 3SS750 AND ORTHO MTS ANTI-IGG GEL CARD LOT 071025001-03 ON THEIR ORTHO WORKSTATION ID-(B)(4). COMPLAINANT: (B)(6) - MEDICAL TECHNOLOGIST; (B)(6); (B)(6) CUSTOMER (B)(6) HOSPITAL(B)(6) DATE OF EVENTS: 06JAN2026 AND 08JAN2026, REPORTED ON 08JAN2026 INSTRUMENT: ORTHO WORKSTATION ID-(B)(4) REAGENTS: SURGISCREEN LOT 3SS750, EXPIRATION: 20JAN2026, MANUFACTURE: 18NOV2025 MTS ANTI-IGG GEL CARD LOT 071025001-03, EXPIRATION: 30APR2026 MANUFACTURE: 31JUL2025 OTHER REAGENTS: 0.8% SURGISCREEN LOT VSS703, EXPIRATION: 20JAN2026 PATIENT INFORMATION: PATIENT 1- SAMPLE ID (B)(6), 29-YEAR-OLD PREGNANT FEMALE WITH CONFIRMED FETAL DEMISE AT 37-WEEKS GESTATION, DIAGNOSED WITH CHRONIC HYPERTENSION IN THE FIRST TRIMESTER AND ON MEDICATION SINCE. ANTI-M(MNS1) ANTIBODY NEWLY IDENTIFIED ON (B)(6) 2026. NO HISTORY OF PREVIOUS TRANSFUSIONS. PATIENT 2- SAMPLE ID (B)(6), 89-YEAR-OLD FEMALE. PREVIOUS HISTORY OF 8-9 YEARS ANEMIA, HY

  Patient problems: No Clinical Signs, Symptoms or Conditions

  MAUDE report 24226375 ↗
• MalfunctionJan 30, 2026False Negative Result

  REPORT 1 OF 2 (B)(4). A CUSTOMER CONTACTED (B)(4) ON (B)(6) 2026 TO REPORT WHAT WAS DESCRIBED AS DISCORDANT NEGATIVE REACTIONS FOR ANTIBODY SCREEN IN INDIRECT ANTIGLOBULIN TEST (IAT) USING MANUAL GEL METHOD, FOR TWO PATIENT SAMPLES UTILIZING REAGENT RED BLOOD CELLS SURGISCREEN LOT 3SS750 AND ORTHO MTS ANTI-IGG GEL CARD LOT 071025001-03 ON THEIR ORTHO WORKSTATION ID-(B)(4). COMPLAINANT: (B)(6)- MEDICAL TECHNOLOGIST; (B)(6); (B)(6) CUSTOMER (B)(6) HOSPITAL (B)(6) DATE OF EVENTS: (B)(6) 2026 AND ( B)(6)2026, REPORTED ON 08JAN2026 INSTRUMENT: ORTHO WORKSTATION ID-MTS, (B)(6) REAGENTS: SURGISCREEN LOT 3SS750, EXPIRATION: 20JAN2026, MANUFACTURE: 18NOV2025 MTS ANTI-IGG GEL CARD LOT 071025001-03, EXPIRATION: 30APR2026 MANUFACTURE: 31JUL2025 OTHER REAGENTS: 0.8% SURGISCREEN LOT VSS703, EXPIRATION: 20JAN2026 PATIENT INFORMATION: PATIENT 1- SAMPLE ID (B)(6), 29-YEAR-OLD PREGNANT FEMALE WITH CONFIRMED FETAL DEMISE AT 37-WEEKS GESTATION, DIAGNOSED WITH CHRONIC HYPERTENSION IN THE FIRST TRIMESTER AND ON MEDICATION SINCE. ANTI-M(MNS1) ANTIBODY NEWLY IDENTIFIED ON (B)(6) 2026. NO HISTORY OF PREVIOUS TRANSFUSIONS. PATIENT 2- SAMPLE ID (B)(6), 89-YEAR-OLD FEMALE. PREVIOUS HISTORY OF 8-9 YEARS ANEMIA

  Patient problems: No Clinical Signs, Symptoms or Conditions

  MAUDE report 24226274 ↗
• MalfunctionJan 30, 2026False Negative Result

  (B)(4) ON (B)(6) 2026, A CUSTOMER CONTACTED THE ORTHO GLOBAL TECHNICAL SOLUTION CENTER (GTSC) AFTER OBSERVING WHAT WAS DESCRIBED AS DISCORDANT NEGATIVE REACTIONS FOR ANTIBODY SCREEN AND ANTIBODY IDENTIFICATION IN INDIRECT ANTIGLOBULIN TEST (IAT) FOR ONE PATIENT SAMPLE USING 0.8% SURGISCREEN LOT VSS701 AND 0.8% RESOLVE PANEL A LOT VRA499 WITH ORTHO MTS ANTI-IGG GEL CARD LOT 072225001-14 ON THEIR ORTHO WORKSTATION ID-MTS (B)(4). COMPLAINANT: (B)(6) USA DATE OF EVENT: 01JAN2026 AND 04JAN2026, REPORTED ON (B)(6) 2026 REAGENTS: 0.8% SURGISCREEN LOT VSS701, EXPIRATION: 06JAN2026, MANUFACTURE: 04NOV2025 0.8% RESOLVE PANEL A LOT VRA499, EXPIRATION: 06JAN2026, MANUFACTURE: 04NOV2025 MTS ANTI-IGG GEL CARD LOT 062525001-29, EXPIRATION: 07JUL2026, MANUFACTURE: 07OCT2025 INSTRUMENTS: ORTHO WORKSTATION ID-MTS (B)(4) PATIENT INFORMATION: MALE, PREVIOUS NEGATIVE ANTIBODY SCREEN ON (B)(6) 2025 PERFORMED AT ANOTHER FACILITY. PREVIOUSLY TRANSFUSED WITH 4 DONOR RED BLOOD CELL UNITS -FROM (B)(6) 2025. RECENTLY TRANSFUSED WITH 2 DONOR RED BLOOD CELL UNITS ON (B)(6) 2026. NEWLY IDENTIFIED ANTI-JKA(JK1) ANTIBODY. THE CUSTOMER REPORTED THAT ON (B)(6) 2026, A SAMPLE FROM THE PATIENT WAS TESTED USING A COMPE

  Patient problems: No Clinical Signs, Symptoms or Conditions

  MAUDE report 24221313 ↗
• MalfunctionDec 18, 2025False Negative Result; False Negative Result

  REPORT 2 OF 2 CMS (B)(4) A CUSTOMER CONTACTED (B)(6) ON (B)(6) 2025 TO REPORT WHAT WAS DESCRIBED AS A DISCORDANT NEGATIVE REACTION IN ANTIBODY SCREEN IN INDIRECT ANTIGLOBULIN TEST (IAT) FOR TWO SAMPLES FROM ONE PATIENT, USING 0.8% SURGISCREEN LOT VSS689 AND ORTHO MTS ANTI-IGG GEL CARD LOT 071025001-04 ON THEIR ORTHO VISION SWIFT ID-MTS ANALYZERS (B)(4). COMPLAINANT/COMPLAINT REPORTER: (B)(6)- MEDICAL TECHNOLOGIST; (B)(6) USA DATE OF EVENTS: 13NOV2025 AND 19NOV2025, REPORTED ON 20NOV2025 INSTRUMENTS: ORTHO VISION SWIFT ID-MTS - (B)(4), SW VERSION 5.16.0 ORTHO VISION SWIFT ID-MTS - (B)(4), SW VERSION 5.16.0 REAGENTS: 0.8% SURGISCREEN LOT VSS689, EXPIRATION: 25NOV2025, MANUFACTURE: 23SEP2025 MTS ANTI-IGG GEL CARD LOT 071025001-04, EXPIRATION: 01MAY2026, MANUFACTURE: 01AUG2025 OTHER REAGENTS: A COMPETITOR'S ANTIBODY SCREEN AND ANTIBODY IDENTIFICATION PANEL RED CELL REAGENTS PATIENT INFORMATION: THE PATIENT HAD A PRIOR ANTIBODY SCREEN PERFORMED ON (B)(6) 2025 RESULTED AS POSITIVE AND A SUBSEQUENT ANTIBODY ID IDENTIFIED A NON-SPECIFIC ANTIBODY. NO HISTORY OF TRANSFUSIONS; NO ADDITIONAL INFORMATION WAS PROVIDED. SAMPLE A- DRAWN (B)(6) 2025, ID (B)(6), ENCRYPTED ID (B)(4) SAMPLE B- DRAWN (

  Patient problems: No Clinical Signs, Symptoms or Conditions

  MAUDE report 23842533 ↗
• MalfunctionDec 18, 2025False Negative Result; False Negative Result

  REPORT 1 OF 2 CMS (B)(6) A CUSTOMER CONTACTED ORTHO GLOBAL TECHNICAL SOLUTION CENTER (GTSC) ON (B)(6) 2025 TO REPORT WHAT WAS DESCRIBED AS A DISCORDANT NEGATIVE REACTION IN ANTIBODY SCREEN IN INDIRECT ANTIGLOBULIN TEST (IAT) FOR TWO SAMPLES FROM ONE PATIENT, USING 0.8% SURGISCREEN LOT: VSS689 AND ORTHO MTS ANTI-IGG GEL CARD LOT: 071025001-04 ON THEIR ORTHO VISION SWIFT ID-MTS ANALYZERS 50004008 AND 50004007. COMPLAINANT/COMPLAINT REPORTER: (B)(6)- MEDICAL TECHNOLOGIST; (B)(6) CUSTOMER (B)(6) USA DATE OF EVENTS: 13NOV2025 AND 19NOV2025, REPORTED ON 20NOV2025 INSTRUMENTS: ORTHO VISION SWIFT ID-MTS - 50004008, SW VERSION 5.16.0 ORTHO VISION SWIFT ID-MTS - 50004007, SW VERSION 5.16.0 REAGENTS: 0.8% SURGISCREEN LOT: VSS689, EXPIRATION: 25NOV2025, MANUFACTURE: 23SEP2025 MTS ANTI-IGG GEL CARD LOT: 071025001-04, EXPIRATION: 01MAY2026, MANUFACTURE: 01AUG2025 OTHER REAGENTS: A COMPETITOR'S ANTIBODY SCREEN AND ANTIBODY IDENTIFICATION PANEL RED CELL REAGENTS PATIENT INFORMATION: THE PATIENT HAD A PRIOR ANTIBODY SCREEN PERFORMED ON (B)(6) 2025 RESULTED AS POSITIVE AND A SUBSEQUENT ANTIBODY ID IDENTIFIED A NON-SPECIFIC ANTIBODY. NO HISTORY OF TRANSFUSIONS; NO ADDITIONAL INFORMATION WAS PROVIDED.

  Patient problems: No Clinical Signs, Symptoms or Conditions

  MAUDE report 23841992 ↗
• MalfunctionDec 15, 2025False Negative Result; False Negative Result

  (B)(4) / RA612822 A CUSTOMER CONTACTED ORTHO GLOBAL TECHNICAL SOLUTION CENTER (GTSC) ON (B)(6) 2025 TO REPORT WHAT WAS DESCRIBED AS A DISCORDANT NEGATIVE REACTION IN ANTIBODY SCREEN IN INDIRECT ANTIGLOBULIN TEST (IAT) FOR ONE PATIENT SAMPLE USING 0.8% SURGISCREEN LOT VSS690 AND ORTHO MTS ANTI-IGG GEL CARD LOT 052025001-01 ON THEIR ORTHO VISION ID-MTS ANALYZER (B)(6). COMPLAINANT/COMPLAINT REPORTER: (B)(6)- MEDICAL TECHNOLOGIST; (B)(6) CUSTOMER (B)(6) DATE OF EVENT: 07NOV2025, REPORTED ON 18NOV2025 INSTRUMENT: ORTHO VISION ID-MTS - (B)(6), SW VERSION 5.16.0 REAGENTS: 0.8% SURGISCREEN LOT VSS690, EXPIRATION: 25NOV2025, MANUFACTURE: 23SEP2025 MTS ANTI-IGG GEL CARD LOT 052025001-01, EXPIRATION: 09MAR2026, MANUFACTURE: 09JUN2025 OTHER REAGENTS: MTS ANTI-IGG GEL CARD LOT 062525001-26, EXPIRATION: 17JUN2026 MTS BUFFERED GEL CARD LOT 033125004-01, EXPIRATION: 07JAN2026 0.8% RESOLVE PANEL B LOT VRB343, EXPIRATION: 25NOV2025 0.8% RESOLVE PANEL C LOT VRC342, EXPIRATION: 25NOV2025 PATIENT INFORMATION: NO PRIOR HISTORY AVAILABLE. SAMPLE A- COLLECTED ON (B)(6) 2025 SAMPLE B- COLLECTED ON (B)(6) 2025 THE CUSTOMER REPORTED THAT ON (B)(6) 2025, A SAMPLE FROM THE PATIENT (SAMPLE A) WAS TESTED FOR AN

  Patient problems: No Clinical Signs, Symptoms or Conditions

  MAUDE report 23802066 ↗
• MalfunctionOct 29, 2025False Negative Result; False Negative Result

  (B)(4) ON (B)(6) 2025, A CUSTOMER CONTACTED ORTHO GLOBAL TECHNICAL SOLUTION CENTER (GTSC) TO REPORT WHAT WAS DESCRIBED AS A DISCORDANT NEGATIVE ANTIBODY SCREENING RESULT IN THE INDIRECT ANTIGLOBULIN TEST (IAT) FOR ONE PATIENT USING REAGENT RED BLOOD CELLS, 0.8% SURGISCREEN LOT VSS683 AND MTS ANTI-IGG GEL CARD LOT 042825001-06 IN CONJUNCTION WITH THEIR ORTHO VISION ID-MTS ANALYZER (B)(6). COMPLAINANT: (B)(6), MEDICAL TECHNOLOGIST: (B)(6), DATE OF EVENT: 03OCT2025, REPORTED ON 06OCT2025, REAGENT(S): 0.8% SURGISCREEN LOT VSS683, EXPIRATION DATE: 28OCT2025, DATE OF MANUFACTURE: 26AUG2025. MTS ANTI-IGG GEL CARD LOT 042825001-06, EXPIRATION DATE: 03MAR2026, DATE OF MANUFACTURE: 03JUN2025. ADDITIONAL REAGENTS: 0.8% RESOLVE PANEL A LOT VRA494, EXPIRATION DATE: 28OCT2025, DATE OF MANUFACTURE: 26AUG2025. MTS ABD MONOCLONAL AND REVERSE GROUPING GEL CARD LOT 041625037-18, EXPIRATION DATE: 28FEB2026, DATE OF MANUFACTURE: 28MAY2025. 0.8% AFFIRMAGEN LOT 8A996, EXPIRATION DATE: 14OCT2025, DATE OF MANUFACTURE: 29JUL2025. ANALYZER: ORTHO VISION ID-MTS, (B)(6), INSTALL DATE: (B)(6) 2019, SW VERSION 5.16.0 PATIENT INFORMATION: SAMPLE ID: (B)(6); ENCRYPTED SAMPLE ID: (B)(6), PREVIOUS ANTIBODY HISTORY N

  Patient problems: No Clinical Signs, Symptoms or Conditions

  MAUDE report 23412118 ↗
• MalfunctionJul 2, 2025False Negative Result; False Negative Result

  (B)(4) / (B)(6) ON (B)(6) 2025, A CUSTOMER CONTACTED THE GLOBAL TECHNICAL SUPPORT CENTER (GTSC) AFTER OBTAINING WHAT WAS DESCRIBED AS A DISCREPANT FALSE NEGATIVE ANTIBODY SCREEN RESULT FOR ONE PATIENT SAMPLE USED FOR COMPETENCY TESTING IN MANUAL GEL METHOD USING 0.8% SURGISCREEN LOT VSS653, EXPIRY 08JUL2025, IN CONJUNCTION WITH MTS ANTI-IGG CARD LOT 021125001-04, EXPIRY 06DEC2025. COMPLAINANT: (B)(6), DATE OF EVENT: 13JUN2025, DATE REPORTED: 13JUN2025 REAGENTS: 0.8% SURGISCREEN LOT VSS653 EXPIRY: 08JUL2025, MANUFACTURED: 06MAY2025 MTS ANTI-IGG GEL CARD LOT 021125001-04 EXPIRY: 06DEC2025, MANUFACTURED: 06MAR2025 INSTRUMENT: ORTHO WORKSTATION ID-MTS, 51002606 ORTHO VISION ID-MTS ANALYZER, 50004450 PATIENT INFORMATION: SAMPLE ID (ENCRYPTED): (B)(6). KNOWN HISTORY OF ANTI-FYB(FY2). NO FURTHER INFORMATION WAS PROVIDED. THE CUSTOMER REPORTED ON (B)(6) 2025 THEY SELECTED A SAMPLE FROM A PATIENT WITH A HISTORY OF ANTIFYB(FY2) TO BE USED FOR BI-ANNUAL SIDE-BY-SIDE METHOD COMPARISON PROFICIENCY TESTING ON THE ORTHO VISION ID-MTS ANALYZER VS. ORTHO WORKSTATION. THE PATIENT SAMPLE WAS THEN TESTED FOR ANTIBODY SCREEN ON THE ORTHO VISION ID-MTS ANALYZER (B)(4), USING 0.8% SURGISCREEN LOT VSS653

  Patient problems: No Clinical Signs, Symptoms or Conditions

  MAUDE report 22384955 ↗
• MalfunctionJul 2, 2025False Negative Result; False Negative Result

  CMS 100244811/100244826, RA611230 A CUSTOMER CONTACTED ORTHO GLOBAL TECHNICAL SUPPORT CENTRE (GTSC) ON 12 JUNE 2025 AFTER OBTAINING WHAT WAS DESCRIBED AS DISCREPANT NEGATIVE ANTIBODY SCREENING RESULTS FOR A PATIENT USING 0.8% SURGISCREEN LOT VSS655 AND ORTHO ID-MTS ANTI-IGG GEL CARD LOT 101824001-05 AND IN CONJUNCTION WITH THEIR ORTHO VISION ID-MTS ANALYSER (50003528) AND ORTHO ID-MTS WORKSTATION (51000948). COMPLAINANT/COMPLAINT REPORTER: DAOPING ZHANG - LABORATORY SUPERVISOR DATE OF EVENTS: 12 JUNE 2025 REPORTED ON: 12 JUNE 2025 BY DAOPING ZHANG TO ORTHO GTSC REAGENTS: 0.8% SURGISCREEN LOT VSS655 EXPIRY DATE 08 JULY 2025 MANUFACTURE DATE 06 MAY 2025 0.8% SURGISCREEN LOT VSS657 EXPIRY DATE 08 JULY 2025 MANUFACTURE DATE 06 MAY 2025 ORTHO ID-MTS ANTI-IGG GEL CARD LOT 101824001-05 EXPIRY DATE 01 AUGUST 2025 MANUFACTURE DATE 01 NOVEMBER 2024 PATIENT INFORMATION: KNOWN ANTI-E(RH3) ANTIBODY THE CUSTOMER REPORTED THAT ON 12 JUNE 2025, THEY HAD TESTED A PATIENT SAMPLE FOR ANTIBODY SCREENING USING 0.8% SURGISCREEN LOT VSS655 AND ORTHO ID-MTS ANTI-IGG GEL CARD LOT 101824001-05 AND IN CONJUNCTION WITH THEIR ORTHO VISION ID-MTS ANALYZER (50003528) AND THAT THEY HAD OBTAINED NEGATIVE REACTIONS

  Patient problems: No Clinical Signs, Symptoms or Conditions

  MAUDE report 22384945 ↗
• MalfunctionJul 2, 2025False Negative Result; False Negative Result

  CMS (B)(4) RA611221 ON (B)(6) 2025, A CUSTOMER CONTACTED THE GLOBAL TECHNICAL SUPPORT CENTER (GTSC) AFTER OBTAINING WHAT WAS DESCRIBED AS A DISCREPANT FALSE NEGATIVE ANTIBODY SCREEN RESULT FOR ONE PATIENT SAMPLE IN MANUAL GEL METHOD USING 0.8% SURGISCREEN LOT VSS655, EXPIRY 08JUL2025, IN CONJUNCTION WITH MTS ANTI-IGG CARD LOT 021125001-08, EXPIRY 12DEC2025. COMPLAINANT: (B)(6), LABORATORY SUPERVISOR (B)(6); (B)(6) DATE OF EVENT: 12JUN2025, DATE REPORTED: 12JUN2025 REAGENTS: 0.8% SURGISCREEN LOT VSS655 EXPIRY: 08JUL2025, MANUFACTURED: 06MAY2025 LOT VSS658 EXPIRY: 22JUL2025, MANUFACTURED: 20MAY2025 MTS ANTI-IGG GEL CARD LOT 021125001-08 EXPIRY: 12DEC2025, MANUFACTURED: 12MAR2025 0.8% RESOLVE PANEL B LOT VRB338 EXPIRY: 08JUL2025, MANUFACTURED: 06MAY2025 PATIENT INFORMATION: PREVIOUS HISTORY OF ANTI-E(RH3), NO FURTHER INFORMATION WAS PROVIDED. THE CUSTOMER REPORTED ON (B)(6) 2025 THEY SELECTED A SAMPLE FROM A PATIENT WITH A HISTORY OF ANTIE(RH3) TO BE USED FOR COMPETENCY TESTING USING MANUAL GEL METHOD. THE CUSTOMER TESTED THE PATIENT SAMPLE UTILIZING 0.8% SURGISCREEN LOT VSS655 AND MTS ANTI-IGG GEL CARD LOT 021125001-08 AND OBTAINED NEGATIVE REACTIONS WITH THE THREE SCREENING CELLS OF

  Patient problems: No Clinical Signs, Symptoms or Conditions

  MAUDE report 22384943 ↗
• MalfunctionApr 3, 2025False Negative Result; False Negative Result

  CMS (B)(4), WINDCHILL RA609454 A CUSTOMER CONTACTED GLOBAL TECHNICAL SOLUTION CENTER (GTSC) ON (B)(6) 2025 AFTER OBSERVING WHAT WAS DESCRIBED AS A DISCORDANT NEGATIVE ANTIBODY SCREENING RESULT IN INDIRECT ANTIGLOBULIN TEST (IAT) USING 0.8% SURGISCREEN LOT VSS628 AND ANTI-HUMAN GLOBULIN ANTI-IGG (RABBIT) MTS ANTI-IGG CARD 111224001-02 IN COMBINATION WITH THEIR ORTHO VISION ID-MTS ANALYZER SERIAL (B)(6) (SOFTWARE VERSION NOT PROVIDED). COMPLAINANT/COMPLAINT REPORTER NAME AND POSITION: (B)(6), MEDICAL TECHNOLOGIST. EVENT DATE: 03MAR2025. PATIENT INFORMATION: KNOWN TO HAVE A MIX OF ANTI-E(RH3) AND ANTI-JKA(JK1) ANTIBODIES SAMPLE ID (B)(6) REAGENTS: 0.8% SURGISCREEN (PRODUCT CODE 6902316; LOT VSS628; EXPIRY DATE 18MAR2025; MANUFACTURE DATE 14JAN2025) ANTI-HUMAN GLOBULIN ANTI-IGG (RABBIT) MTS ANTI-IGG CARD 111224001-02 (PRODUCT CODE MTS084024; EXPIRY DATE 20AUG2025; MANUFACTURE DATE 20NOV2024) 0.8% SURGISCREEN (PRODUCT CODE 6902316; LOT VSS617; EXPIRY DATE 18FEB2025; MANUFACTURE DATE 17DEC2024) THE CUSTOMER REPORTED THAT ON (B)(6) 2025, THEY HAD TESTED SAMPLE ID (B)(6) FROM THIS PATIENT FOR ANTIBODY SCREENING IN IAT USING 0.8% SURGISCREEN LOT VSS617 AND ANTI-HUMAN GLOBULIN ANTI-IGG (RABB

  Patient problems: No Clinical Signs, Symptoms or Conditions

  MAUDE report 21761151 ↗
• MalfunctionMar 12, 2025False Negative Result; False Negative Result

  WINDCHILL CI0003987 CMS (B)(4) A CUSTOMER CONTACTED GLOBAL TECHNICAL SOLUTION CENTER (GTSC) ON (B)(6)2025 AFTER OBSERVING WHAT WAS DESCRIBED AS A DISCORDANT NEGATIVE ANTIBODY SCREENING RESULTS IN INDIRECT ANTIGLOBULIN TEST (IAT) FOR ONE PATIENT USING 0.8% SURGISCREEN FOR GEL LOT VSS622 AND ORTHO MTS ANTI-IGG CARD LOTS 060724001-22 AND 072224001-15 IN CONJUNCTION WITH THEIR ORTHO VISION ID-MTS ANALYZERS (B)(6). COMPLAINANT/COMPLAINT REPORTER: (B)(6); MEDICAL TECHNOLOGIST DATE OF EVENTS: 14 AND 19 FEB2025; REPORTED ON: (B)(6) 2025 BY CUSTOMER TO ORTHO GTSC REAGENTS: 0.8% SURGISCREEN LOT VSS622 EXPIRY DATE 04MAR2025, MANUFACTURE DATE 31DEC2024 ORTHO MTS ANTI-IGG CARD LOT 060724001-22 EXPIRY DATE 30APR2025, MANUFACTURE DATE 31JUL2024 ORTHO MTS ANTI-IGG CARD LOT 072224001-15 EXPIRY DATE 16MAY2025, MANUFACTURE DATE 16AUG2024 PATIENT INFORMATION: SAMPLE ID (B)(6)THE CUSTOMER STATED THAT ON (B)(6)2025, THEY HAD TESTED A PATIENT SAMPLE (SAMPLE ID (B)(6) FOR ANTIBODY SCREENING IN IAT USING 0.8% SURGISCREEN LOT VSS622 AND ORTHO MTS ANTI-IGG CARD LOT 060724001-22 IN CONJUNCTION WITH THEIR ORTHO VISION ID-MTS ANALYZER (B)(6) AND THAT THEY HAD OBTAINED NEGATIVE REACTIONS WITH THE THREE CELLS OF

  Patient problems: No Clinical Signs, Symptoms or Conditions

  MAUDE report 21582022 ↗

Other Ortho-Clinical Diagnostics, Inc. products

• VITROS71 models · 806 reports · 96 recalls
• BIOCLONE3 models · 8 reports · 1 recall
• RESOLVE3 models · 38 reports